Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-55
SponsorNovoBliss Research Pvt Ltd

About this trial

This is a randomized, double-blind, comparative, two-arm, prospective, interventional, multi-centre clinical study to evaluate the safety, efficacy, and in-use tolerability of test products, standardized saffron extract capsules, on skin rejuvenation and age-defying benefits in healthy adult male and female subjects.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: 30 to 55 years (both inclusive) at the time of consent.

Sex: Adult male and female having wrinkles and fine lines at crow feet's area, facial hyperpigmentation and dark spots such as tan, pimple marks, sunspots, age spots, uneven skin tone on both side of face.

Females of childbearing potential should have a self-reported negative urine pregnancy test at the time of screening visit.

Subjects should not have used any cosmetic, nutraceutical or therapeutic products for skin ageing in last 1 month.

Disqualifiers

Subjects who are on steroids for last six months and using immunosuppressive, anti-inflammatory, or hormone-modulating medications that may interfere with study outcomes.

Subjects who have used any cosmetic, nutraceutical or therapeutic products for skin last one months.

Subjects currently using any oral supplement and topical products containing kojic acid, glycolic acid, niacinamide, alpha arbutin, vitamin C, retinoids, peptides, exfoliating acids, or any other skin-lightening, anti-ageing, or depigmenting agents within the past 4 weeks.

Subjects with a known history of hypersensitivity, allergic reactions, or intolerance (such as drowsiness, stomach discomfort, nausea, or vomiting).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standardized Saffron Extract (Crocus Sativus L) 10 mg Capsule

    Dietary supplement

    Mode of Usage: Administer one capsule once daily after meal, ideally at the same time each day to maintain consistency in absorption. Swallow the capsule whole with a full glass of water; do not crush, break, or chew the capsule. Frequency: Once a day, after lunch Route of administration: Oral Storage Condition: Store in cool and dry place, away from sunlight, heat and moisture.

  • Placebo (capsules containing Maltodextrin, Calcium carbonate, Sunset yellow, Maize starch, Mg Stearate, Talc)

    Other intervention

    Mode of Usage: Administer one capsule once daily after meal, ideally at the same time each day to maintain consistency in absorption. Swallow the capsule whole with a full glass of water; do not crush, break, or chew the capsule. Frequency: Once a day, after lunch Route of administration: Oral Storage Condition: Store in cool and dry place, away from sunlight, heat and moisture.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Standardized Saffron Extract (Crocus Sativus L) 10 mg CapsuleExperimental treatment 1 intervention
Group B: Placebo ( Maltodextrin, Calcium carbonate, Sunset yellow, Maize starch, Mg Stearate, Talc)Placebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

To evaluate the effectiveness of test products in terms of change in facial wrinkles and finelines of Crow's feet area, skin texture -dryness, roughness, smoothness, pores within and between product groups

By using Visioscan® VC 20 Plus

Time frame
Baseline on Day 01 and post usage of test products on Day 45 (±2 Days), Day 90 (±2 Days), Day 120 (±2 Days)
2

To evaluate the effectiveness of test products by assessing change in skin tone - L*, a*, b*, and ITA within and between product groups

By using Skin Colorimeter CL 400

Time frame
Baseline on Day 01 and post usage of test products on Day 45 (±2 Days), Day 90 (±2 Days), Day 120 (±2 Days)

Secondary outcomes

1

To evaluate the effectiveness of test products by assessing change in skin elasticity and firmness within and between product groups

By using Cutometer Dual MPA 580 (R0 and R2)

Time frame
Baseline on Day 01 and post usage of test products on Day 45 (±2 Days), Day 90 (±2 Days), Day 120 (±2 Days)
2

To evaluate the effectiveness of test products by assessing change in skin texture such as skin dryness, redness, fine lines, coarse wrinkles, laxity, roughness and sallowness within and between product groups

By Physician Global Assessment (PGA) using Griffith's scale by Dermatologist or dermatologist trained evaluator

Time frame
from baseline on Day 01 and post usage of test products on Day 45 (±2 Days) and Day 90 (±2 Days)
3

To evaluate the effectiveness of test products by assessing change in wrinkles within and between product groups

Evaluated through Dermatological Evaluation using Glogau Scoring Scale

Time frame
from baseline on Day 01 and post usage of test products on Day 45 (±2 Days) and Day 90 (±2 Days)
4

4. To evaluate the effectiveness of test products by assessing change in skin pigmentation evaluated through Dermatological Evaluation using Skin Pigmentation Scoring within and between product groups.

By using Melasma Area and Severity Index Scale

Time frame
From baseline on Day 01 and post usage of test products on Day 45 (±2 Days) and Day 90 (±2 Days)

Other outcomes

1

To evaluate the safety of the test product by clinical laboratory parameters

complete blood count (CBC), Biochemistry, Urinalysis

Time frame
From baseline on 07 days prior to day 01 to post-product on Day 90 (±2 Days).
2

To evaluate the safety of the test product

By the monitoring of product emergent systematic evaluation of adverse events

Time frame
Post-product on Day 45(±2 Days) and Day 90 (±2 Days)
3

To evaluate the safety of the test treatment by checking compliance towards the test treatments and daily diary entries

For compliance-capsule counts

Time frame
From baseline to post-treatment on Day 45(±2 Days) and Day 90 (±2 Days)

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

NovoBliss Research Pvt Ltd

Lead sponsor

Pharmanza Herbal Private Ltd

Collaborator

This trial is not recruiting at the moment. You can still explore other options: